Assuntos

RESUMO

Trata la pediatría en general, tocando especialmente temas de: Crecimiento y desarrollo, nutrición, trastornos de nutrición, salud mental, inmunologías y alergias, enfermedades del tejido conectivo, génetica, neonatología, medio interno, enfermedades infecciosas, aparato respiratorio, digestivo, cardiovascular, riñon y vías urinarias, sistema endócrino, sangre y órganos linfáticos, oncología, sistema nervioso, patologías quirúrgicas, patología ortopédica y traumatológica, daños relacionados con el medio ambiente, ginecología, oftalmología, enfermedades de la piel, problemas odontológicos, diagnóstico por imagenes, farmacoterapia, procedimientos en pediatría, consultas más frecuentes, error de diagnóstico, análisis y evaluación bibliográfica, valores de laboratorio y tablas de uso habitual.

Assuntos

Assuntos

Assuntos

RESUMO

Six hundred and thirty-one patients with hemolytic uremic syndrome (HUS) were treated from 1960 to 1992; 19 (3%) were familial cases, of which 9 were classified as concomitant (including twins), 6 as non-concomitant, and 4 as recurrent. In the recurrent group there were 15 HUS episodes, 10 being concomitant in 2 patients. Prodromal diarrhea was present only in concomitant and non-concomitant cases. Patients with recurrences were sisters from a single family. Concomitant and non-concomitant cases had clinical features, course, and age similar to typical endemoepidemic forms of HUS, in which an association with verocytotoxin-producing Escherichia coli has been reported. There may be a genetic determinant in concomitant cases; these occurred outside the season during which endemoepidemic forms are typically detected. In patients with recurrent disease a genetic factor which may lead to the development of the disease when triggered by viral infections is likely.

Assuntos

RESUMO

Thirty-four hemolytic uremic syndrome (HUS) patients and ninety-five family members were studied to determine the frequency of infection with verocytotoxin-producing Escherichia coli (VTEC) in household contacts using three diagnostic criteria: VTEC strains isolation and characterization, detection of free fecal VT (FVT) and VT-neutralizing antibodies (VT-NAbs). Gastrointestinal tract symptoms occurred in one to six family members in 8 (23.5%) of the index cases, the week before admission to hospital or simultaneously. The control group consisted of 34 children with acute gastroenteritis who did not develop HUS. Cumulative evidence of VTEC infection was found in 13 (38.2%) of 34 HUS patients, in 30 (31.6%) of 95 family members and in 10 (29.4%) of 34 control children. The serotypes of VTEC isolated were O157: H7 and O25: H2. The prevalent VT type was VT2 in VTEC and FVT; and VT1 in VT-NAbs. Both parents had the same infection rate by fecal toxin or serological data (11.1% FVT, 32% VT-NAbs). These were higher than those detected in siblings (6.2% FVT, 23.5% VT-NAbs) and grandparents (0% FVT, 18% VT-NAbs). Of 16 patients without evidence of infection, 3 had household contacts with FVT and 13 with VT-NAbs. Our results show the wide dissemination of VTEC in the population of Argentina and that family members of HUS patients are usually infected. Therefore, person-to-person transmission may play an important role in the high incidence of HUS in our country.

Assuntos

RESUMO

A female neonate, born by cesarean section at 37 weeks of gestation, presented with respiratory distress syndrome, right pneumothorax and anuria. A sonogram showed increased echogenicity, with neither hydronephrosis nor macroscopic cysts. Peritoneal dialysis was started on the 14th day because of renal insufficiency, but the newborn died on the 33rd day. Family history was unremarkable, except that the mother received piroxicam at about the 26th week of gestation. A sonogram at the 28th week showed oligohydramnios. Histopathological study of the kidneys revealed crowded glomeruli and only few differentiated proximal convoluted tubules in the inner cortex, abnormally differentiated microcystic tubules and microcystic glomeruli in the outer cortex. Periodic acid-Schiff staining showed only traces of brush border in the dilated tubules of the outer cortex. Immunoperoxidase staining for epithelial membrane antigen was positive in the luminal border of all tubules. Electron microscopy confirmed the presence of brush border remnants and other proximal tubular characteristics in some segments. The renal abnormality bears some similarities to that found in familiar renal tubular dysgenesis, but it fits better with those described after maternal use of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs. The lesion in this case appears to have resulted from fetal exposure to piroxicam. Recently, a second pregnancy ended in a completely normal female newborn.

Assuntos

RESUMO

We report a case of a child who developed Hemolytic Uremic Syndrome in whom two Shiga-like toxin (SLT)-producing Escherichia coli strains of different serotypes and genotypes, were simultaneously isolated from stools. In addition, one of these strains represented a new toxin producing serotype. Strain 1 belonged to serotype O157: H7, biotype D, produced SLT II and was susceptible to all antibiotics tested. This strain hybridized with gene probes for SLT II, fimbrial adhesion (EHEC factor) and attaching and effacing factor (eae). Strain 2 belonged to serotype 025: K2: H2, produced SLT II and had a multiresistant antibiotic susceptibility pattern. This strain hybridized with the EHEC gene probe but not with SLT I, SLT II and eae gene probes. Free fecal SLT II cytotoxin was detected in stools of the child and his father, suggesting that the infection may have been acquired from a household contact.

Assuntos

RESUMO

Se presenta el caso de un niño de 14 meses que desarrolló Sindrome Urémico Hemolítico después de un período prodrómico con vómitos y diarrea mucosanguinolenta del cual se aislaron 2 cepas de E. coli productoras de toxina simil-Shiga (SLT) de diferente serotipo y genotipo. Una de las cepas correspondió al seotipo 0157: H7, biotipo D, productora de SLT II y susceptible a todos los antibióticos probados. Esta cepa hibridizó cona las sondas genéticas para SLT II; la fimbria de adherencia (factor EHEC) y para el factor de fijación y disolución del borde en cepillo ("E. coli attaching and effacing") eae). La otra cepa correspondió al serotipo O25:K2:H2 productora de SLT II en los ensayos de neutralización de efecto citotóxico sobre células VERO utilizando anticuerpos monoclonales, pero negativas para SLT I y SLT II y el factor eae. Sólo fue positiva por hibridización con la sonda para la fimbria de adherencia. Esta cepa presentó además un patron de multiresistencia a los antibióticos probados. Por otra parte, la cepa de E. coli, del serotipo O25: K2: H2 produjo niveles tanto de toxina libre como asociada a células, 20 veces superiores a la cepa del serotipo O157:H7. Esta es la primera publicación de un caso de SUH en el cual se detectó una cepa de E. coli del serotipo O25:H2 produjo niveles tanto de toxina libre como asociada a células, 20 veces superiores a la cepa del serotipo O157:H7. Esta es la primera publicación de un caso de SUH en el cual se detectó una cepa de E. coli del serotipo O25:H2 productora de SLT. Además el hecho de no hibridizar con la sonda genética para SLT II, a pesar de tener una actividad citotóxica neutralizable por el anticuerpo monoclonal (MAb BC5BB12) indicaria que la secuencia que codifica para SLT II no presenta homología con la sonda utilizada. la detección de SLT libre tanto en la materia fecal del niño como en la de su padre (quien padeció diarrea una semana antes), indicaría que el niño adquirió la infección en el entorno familiar

Assuntos

RESUMO

We report a case of a child who developed Hemolytic Uremic Syndrome in whom two Shiga-like toxin (SLT)-producing Escherichia coli strains of different serotypes and genotypes, were simultaneously isolated from stools. In addition, one of these strains represented a new toxin producing serotype. Strain 1 belonged to serotype O157: H7, biotype D, produced SLT II and was susceptible to all antibiotics tested. This strain hybridized with gene probes for SLT II, fimbrial adhesion (EHEC factor) and attaching and effacing factor (eae). Strain 2 belonged to serotype 025: K2: H2, produced SLT II and had a multiresistant antibiotic susceptibility pattern. This strain hybridized with the EHEC gene probe but not with SLT I, SLT II and eae gene probes. Free fecal SLT II cytotoxin was detected in stools of the child and his father, suggesting that the infection may have been acquired from a household contact.

RESUMO

Se presenta el caso de un niño de 14 meses que desarrolló Sindrome Urémico Hemolítico después de un período prodrómico con vómitos y diarrea mucosanguinolenta del cual se aislaron 2 cepas de E. coli productoras de toxina simil-Shiga (SLT) de diferente serotipo y genotipo. Una de las cepas correspondió al seotipo 0157: H7, biotipo D, productora de SLT II y susceptible a todos los antibióticos probados. Esta cepa hibridizó cona las sondas genéticas para SLT II; la fimbria de adherencia (factor EHEC) y para el factor de fijación y disolución del borde en cepillo ("E. coli attaching and effacing") eae). La otra cepa correspondió al serotipo O25:K2:H2 productora de SLT II en los ensayos de neutralización de efecto citotóxico sobre células VERO utilizando anticuerpos monoclonales, pero negativas para SLT I y SLT II y el factor eae. Sólo fue positiva por hibridización con la sonda para la fimbria de adherencia. Esta cepa presentó además un patron de multiresistencia a los antibióticos probados. Por otra parte, la cepa de E. coli, del serotipo O25: K2: H2 produjo niveles tanto de toxina libre como asociada a células, 20 veces superiores a la cepa del serotipo O157:H7. Esta es la primera publicación de un caso de SUH en el cual se detectó una cepa de E. coli del serotipo O25:H2 produjo niveles tanto de toxina libre como asociada a células, 20 veces superiores a la cepa del serotipo O157:H7. Esta es la primera publicación de un caso de SUH en el cual se detectó una cepa de E. coli del serotipo O25:H2 productora de SLT. Además el hecho de no hibridizar con la sonda genética para SLT II, a pesar de tener una actividad citotóxica neutralizable por el anticuerpo monoclonal (MAb BC5BB12) indicaria que la secuencia que codifica para SLT II no presenta homología con la sonda utilizada. la detección de SLT libre tanto en la materia fecal del niño como en la de su padre (quien padeció diarrea una semana antes), indicaría que el niño adquirió la infección en el entorno familiar (AU)

Assuntos

RESUMO

Twenty-two infants with moderate dehydration due to diarrhea in whom oral rehydration therapy (ORT) was contraindicated or who failed to respond to this method of therapy were treated with rapid intravenous rehydration (RIR). Clinical signs of dehydration without shock allowed us to estimate 5% to 10% of weight loss. Patients were 11 days to 19 months old, and 9 of them were undernourished. A standard solution containing 90 mmol/L sodium, 80 mmol/L chloride, 30 mmol/L bicarbonate, 20 mmol/L potassium and 111 mmol/L glucose was used for all patients. The IV infusion was maintained until the rehydration was completed at a rate of 15 to 20 mL/kg/hour. Complete rehydration was successfully achieved in all patients. A total of 89.5 +/- 25.0 mL/kg (mean +/- SD) was needed and the duration of the IV infusion was 5.1 +/- 1.6 hours. Weight gain achieved was 6.5 +/- 1.6%. None of the patients developed hypernatremia following treatment. The initial base deficit, -9.5 +/- 6.6, was reduced to -3.5 +/- 2.9. All of the patients tolerated refeeding immediately after completion of the IV infusion. Our study suggests that this modality of rehydration is well tolerated, safe and effective and enhances the possibility of an early hospital discharge.

Assuntos

RESUMO

The aim of this study was to investigate the effect of furosemide on urinary acidification in 7 healthy children (aged 7 to 9 years) 5 patients with normokalemic distal renal tubular acidosis (RTA) (aged 4 to 13 years) and in 1 patient with proximal RTA (aged 20 months). Furosemide was given (2 mg/kg orally) as a tool to stimulate H+ and K+ secretion by enhancing Na delivery and transport in distal tubular segments. Patients with distal RTA were diagnosed by means of the ammonium chloride test and the alkaline overload and the one with proximal RTA by the ammonium chloride test only. Urinary acidification was evaluated 1 hour before and until 4 hours after furosemide administration. Healthy children (Fig. 1) showed a significant fall in urinary pH, 5.8 +/- 0.27 to 4.88 +/- 0.18 (p less than 0.02) and increase of NH3 excretion from 38.58 +/- 10.33 to 79.09 +/- 10.38 microEq/min/1.73 m2 (p less than 0.05). There was a direct correlation between urinary pH and urinary flow: r = 0.62 p less than 0.01 (Fig. 3). In patients with distal RTA (Fig. 5) furosemide failed to lower urine pH below 6 and net acid excretion persisted low: 47.9 +/- 6.1 microEq/min/1.73 m2. In the patient with proximal RTA (Fig. 4) furosemide produced the same effect as in healthy children with a fall in urine pH to 4.4 and an increase in net acid excretion to 118 microEq/min/1.73 m2. Furosemide proved to be effective to differentiate the type of RTA.(ABSTRACT TRUNCATED AT 250 WORDS)

Assuntos

RESUMO

Se estudiaron 7 niños sanos de 5 a 9 años de edad, 5 con acidose túbulo renal (ATR) distal no hiperkalémica de 4 a 13 años y 1 con ATR proximal de 20 meses para ver le efecto de la furosemida sobre la acidificación urinaria comparándola con las pruebas de sobrecarga ácida y alcalina. Una hora antes y hasta 4 horas después del suministro de furosemida 2 mg/kg por vía oral se medió pH, pCO2, AT, NH3, creatinina y electrolitos en orina cada 60 minutos y creatinina, pH, PCO2 y electrolitos en sangre al comienzo y al final de la prueba. En los ninos sanos y en el paciente con ATR proximal se comprobó significativa caída del pHu y aumento de la excreción ácida neta. Hubo correlación directa entre pH y flujo urinario. En los niños con ATR distal normokalémica la furosemida no hizo descender el pHu a menos de 6 y la excreción ácida neta permaneció baja. El estímulo sobre la secreción distal de hidrógeno que provocó la furosemida en niños sanos y con ATR proximal podría explicarse por un aumento de la oferta y transporte de sodio en el túbulo colector cortical. En los niños con ATR distal normokalémica, estaría implicada una falla en la secreción ...

Assuntos

RESUMO

The aim of this study was to investigate the effect of furosemide on urinary acidification in 7 healthy children (aged 7 to 9 years) 5 patients with normokalemic distal renal tubular acidosis (RTA) (aged 4 to 13 years) and in 1 patient with proximal RTA (aged 20 months). Furosemide was given (2 mg/kg orally) as a tool to stimulate H+ and K+ secretion by enhancing Na delivery and transport in distal tubular segments. Patients with distal RTA were diagnosed by means of the ammonium chloride test and the alkaline overload and the one with proximal RTA by the ammonium chloride test only. Urinary acidification was evaluated 1 hour before and until 4 hours after furosemide administration. Healthy children (Fig. 1) showed a significant fall in urinary pH, 5.8 +/- 0.27 to 4.88 +/- 0.18 (p less than 0.02) and increase of NH3 excretion from 38.58 +/- 10.33 to 79.09 +/- 10.38 microEq/min/1.73 m2 (p less than 0.05). There was a direct correlation between urinary pH and urinary flow: r = 0.62 p less than 0.01 (Fig. 3). In patients with distal RTA (Fig. 5) furosemide failed to lower urine pH below 6 and net acid excretion persisted low: 47.9 +/- 6.1 microEq/min/1.73 m2. In the patient with proximal RTA (Fig. 4) furosemide produced the same effect as in healthy children with a fall in urine pH to 4.4 and an increase in net acid excretion to 118 microEq/min/1.73 m2. Furosemide proved to be effective to differentiate the type of RTA.(ABSTRACT TRUNCATED AT 250 WORDS)

RESUMO

Se estudiaron 7 niños sanos de 5 a 9 años de edad, 5 con acidose túbulo renal (ATR) distal no hiperkalémica de 4 a 13 años y 1 con ATR proximal de 20 meses para ver le efecto de la furosemida sobre la acidificación urinaria comparándola con las pruebas de sobrecarga ácida y alcalina. Una hora antes y hasta 4 horas después del suministro de furosemida 2 mg/kg por vía oral se medió pH, pCO2, AT, NH3, creatinina y electrolitos en orina cada 60 minutos y creatinina, pH, PCO2 y electrolitos en sangre al comienzo y al final de la prueba. En los ninos sanos y en el paciente con ATR proximal se comprobó significativa caída del pHu y aumento de la excreción ácida neta. Hubo correlación directa entre pH y flujo urinario. En los niños con ATR distal normokalémica la furosemida no hizo descender el pHu a menos de 6 y la excreción ácida neta permaneció baja. El estímulo sobre la secreción distal de hidrógeno que provocó la furosemida en niños sanos y con ATR proximal podría explicarse por un aumento de la oferta y transporte de sodio en el túbulo colector cortical. En los niños con ATR distal normokalémica, estaría implicada una falla en la secreción ... (AU)

Assuntos

Assuntos

Assuntos

Assuntos